This trial examines the effects of a retatrutide weekly injection on cardiovascular outcomes in obese (>35 BMI) patients who have had a heart attack, stroke or have symptomatic peripheral arterial disease.

Please contact us for more information: research@nightingalecardiology.com or call us on (08) 7444 4219